Sergio Traversa, CEO at RELMADA THERAPEUTICS, INC. (RLMD), sold 19,900 shares at $32.86 ($644K) on 2021-01-27, disclosed to the SEC on 2021-01-29.
Open-market sale of $644k RLMD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.77 | 4,351 | $138K | 21.4% |
| 2 | $31.77 | 4,351 | $138K | 21.4% |
| 3 | $32.86 | 5,549 | $182K | 28.3% |
| 4 | $32.86 | 5,549 | $182K | 28.3% |
| 5 | $33.43 | 100 | $3K | 0.5% |
| Total | $32.39 avg | 19,900 |
| $644K |
| 100% |
| Filing → |
| RLMD | BUY | 2025-11-06 | $600K | — | Filing → |
| RLMD | BUY | 2025-08-28 | $265K | — | Filing → |
| RLMD | BUY | 2025-05-20 | $335K | — | Filing → |